Deep learning to guide Molecular pathology - What this means for your lab?
Cancer care has evolved over time to precise, targeted & personalized therapy options. This evolution is primarily fueled by molecular pathology, which is now under pressure from increasing tests and a shortage of pathologists.
sponsored by Philips
Cancer care has evolved over time to precise, targeted & personalized therapy options. This evolution is primarily fueled by molecular pathology, which is now under pressure from increasing tests and a shortage of pathologists. Join Prof. Manuel Salto-Tellez, Queens University Belfast & Dr. Peter Hamilton, Business Lead for Philips DPS to discover how Philips deep learning software, TissueMark will assist by reducing the workload for your molecular lab through automated annotation of digital H&E tumor tissue image and cellular profile estimation to facilitate high impact molecular tests.
What you will learn about TissueMark:
- Potential to save valuable time of lab personnel with a streamlined, high throughput routine workflow with easy access to case information
- Enables accurate region of interest detection and cellular profile estimation
- Facilitate streamline biomarker discovery & research
**TissueMark is a research application and not intended for diagnostic, monitoring or therapeutic purposes or in any other manner for regular medical practice.. PathXL is the legal manufacturer of TissueMark, a Philips company.
